Literature DB >> 29393768

The contribution of secondhand tobacco smoke exposure to pediatric multiple sclerosis risk.

Amy M Lavery1, Bradley N Collins2, Amy T Waldman3, Chantelle N Hart4, Amit Bar-Or5, Ruth Ann Marrie6, Douglas Arnold7, Julia O'Mahony8, Brenda Banwell3.   

Abstract

BACKGROUND: Pediatric acquired demyelinating syndromes (ADSs) are monophasic (mono-ADS) in 70% of cases and represent the first attack of multiple sclerosis (MS) in 30%. Secondhand tobacco smoke (SHS) exposure has been implicated as a risk factor for adult-onset MS. Little is known about whether SHS presents an additive risk beyond genetic factors and other environmental exposures associated with pediatric MS.
METHODS: This study examined SHS exposure in 216 children with mono-ADS and 81 children with MS. Interactions between SHS, HLA-DRB1*15 alleles, serum 25-hydroxyvitamin D concentrations, and serological evidence of remote Epstein-Barr virus (EBV) exposure were evaluated.
RESULTS: SHS exposure was more common in children with MS (37% exposed) compared to mono-ADS (29.5% exposed). Compared to mono-ADS, SHS exposure was not an independent risk factor for MS. When both SHS exposure and HLA-DRB1*15 were present, the odds for MS increased (odds ratio (OR) = 3.7; 95% confidence interval (CI): 1.17-11.9) compared to mono-ADS. Interactions between SHS and vitamin D or EBV did not associate with MS.
CONCLUSION: Exposure to SHS is a risk factor for central nervous system (CNS) demyelination. Results suggest that SHS exposure and HLA-DRB1*15 interact to increase risk for MS in children diagnosed with mono-ADS.

Entities:  

Keywords:  Multiple sclerosis; epidemiology

Mesh:

Substances:

Year:  2018        PMID: 29393768     DOI: 10.1177/1352458518757089

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  6 in total

1.  Gene-environment interactions increase the risk of pediatric-onset multiple sclerosis associated with ozone pollution.

Authors:  Amin Ziaei; Amy M Lavery; Xiaorong Ma Shao; Cameron Adams; T Charles Casper; John Rose; Meghan Candee; Bianca Weinstock-Guttman; Greg Aaen; Yolanda Harris; Jennifer Graves; Leslie Benson; Mark Gorman; Mary Rensel; Soe Mar; Tim Lotze; Benjamin Greenberg; Tanuja Chitnis; Janace Hart; Amy T Waldman; Lisa F Barcellos; Emmanuelle Waubant
Journal:  Mult Scler       Date:  2022-01-08       Impact factor: 5.855

Review 2.  Pediatric Multiple Sclerosis: an Update.

Authors:  Scott Otallah; Brenda Banwell
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-18       Impact factor: 5.081

3.  Enhancing Mood, Cognition, and Quality of Life in Pediatric Multiple Sclerosis.

Authors:  Cristina Fernandez-Carbonell; Leigh E Charvet; Lauren B Krupp
Journal:  Paediatr Drugs       Date:  2021-05-17       Impact factor: 3.022

4.  Cognitive Functioning in Patients with Pediatric-Onset Multiple Sclerosis, an Updated Review and Future Focus.

Authors:  Joy B Parrish; Emily Fields
Journal:  Children (Basel)       Date:  2019-02-04

Review 5.  Preventing Multiple Sclerosis: The Pediatric Perspective.

Authors:  Duriel Hardy; Tanuja Chitnis; Emmanuelle Waubant; Brenda Banwell
Journal:  Front Neurol       Date:  2022-02-25       Impact factor: 4.003

6.  Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors.

Authors:  Benjamin M Jacobs; Gavin Giovannoni; Jack Cuzick; Ruth Dobson
Journal:  Mult Scler       Date:  2020-03-23       Impact factor: 6.312

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.